Measles-containing-vaccine second-dose (MCV2) immunization coverage in Switzerland
Switzerland: Measles-containing-vaccine second-dose (MCV2) immunization coverage was 92.0% in 2025. ▲ Rising
Measles-containing-vaccine second-dose (MCV2) immunization coverage in Switzerland, 2000–2025
Source: World Health Organization, Global Health Observatory.
Analysis
In 2025, measles-containing-vaccine second-dose (mcv2) immunization coverage in Switzerland stood at 92.0%.
Compared with earlier readings it is down 1.1% on the previous year and up 5.7% over ten years.
Over the whole period, measles-containing-vaccine second-dose (mcv2) immunization coverage in Switzerland peaked at 94.0% in 2021 and was at its lowest, 0.0%, in 2000.
That places Switzerland 56th out of 194 countries with data for 2025, putting it in the middle of the range.
The long-run direction has been consistently rising across the 26 years of available data.
Measles-containing-vaccine second-dose (MCV2) immunization coverage in Switzerland, year by year
| Year | Value | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 0.0% | — |
| 2004 | 0.0% | — |
| 2005 | 71.0% | — |
| 2006 | 71.0% | +0.0% |
| 2007 | 71.0% | +0.0% |
| 2008 | 83.0% | +16.9% |
| 2009 | 83.0% | +0.0% |
| 2010 | 83.0% | +0.0% |
| 2011 | 86.0% | +3.6% |
| 2012 | 86.0% | +0.0% |
| 2013 | 86.0% | +0.0% |
| 2014 | 87.0% | +1.2% |
| 2015 | 87.0% | +0.0% |
| 2016 | 87.0% | +0.0% |
| 2017 | 90.0% | +3.4% |
| 2018 | 90.0% | +0.0% |
| 2019 | 90.0% | +0.0% |
| 2020 | 93.0% | +3.3% |
| 2021 | 94.0% | +1.1% |
| 2022 | 94.0% | +0.0% |
| 2023 | 91.0% | -3.2% |
| 2024 | 93.0% | +2.2% |
| 2025 | 92.0% | -1.1% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 37.9% | 0.0% | 83.0% | 10 |
| 2010s | 87.2% | 83.0% | 90.0% | 10 |
| 2020s | 92.8% | 91.0% | 94.0% | 6 |
Countries ranked near Switzerland
More health data for Switzerland
- Un projection of annual infant deaths, annual growth rate -2.13 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -1.27 % change on previous year (2090)
- Heat deaths vs projected death rates 1,104 (2090)
- Un projection of annual infant deaths 46 (2100)
- Population ages 65 and above, total, annual growth rate 3.05 % change on previous year (2025)
- Population ages 65 and above, total, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 65 and above, total, per capita 0.2043 units per person (2025)
- Population, female, annual growth rate 0.9336 % change on previous year (2025)
- Population, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population, female, per capita 0.5031 units per person (2025)
Frequently asked questions
- What is measles-containing-vaccine second-dose (mcv2) immunization coverage in Switzerland?
- Measles-containing-vaccine second-dose (mcv2) immunization coverage in Switzerland was 92.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest measles-containing-vaccine second-dose (mcv2) immunization coverage recorded in Switzerland?
- The highest recorded value was 94.0% in 2021.
- What is the lowest measles-containing-vaccine second-dose (mcv2) immunization coverage recorded in Switzerland?
- The lowest recorded value was 0.0% in 2000.
- How does Switzerland rank for measles-containing-vaccine second-dose (mcv2) immunization coverage?
- Switzerland ranks 56th out of 194 countries with data for 2025.
- Is measles-containing-vaccine second-dose (mcv2) immunization coverage rising or falling in Switzerland?
- Over the last ten years it is up 5.7%. The long-run trend across the full record is rising.
- Where does this Switzerland data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Measles-containing-vaccine second-dose (MCV2) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 26 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).